Caspase-3 |
Activation of caspase-3 and downregulation of antiapoptotic gene |
Brain |
Oxidative DNA damage, ROS-induced carcinogenesis, neurodegeneration |
[177, 178] |
Reactive oxygen species (ROS) |
ROS level increases, increased apoptosis |
[179–181] |
Na-K ATPase |
Increased activity of Na-K ATPase and increased membrane excitability |
[182, 183] |
Corticosterone |
Increased level |
Plasma |
[184] |
Leucocyte |
Increased leucocyte count |
Plasma |
Higher titer of antinuclear antibodies, worsen immune functions, Early onset of Autoimmune and inflammatory diseases, modulate blood-brain barrier |
[184] |
Lymphocytes |
Decreased number of lymphocytes |
[184] |
Natural killer (NK) cells |
Increased number of NK cells |
[185] |
Cytokines |
Elevation of pro-inflammatory cytokines (IL-6) |
Plasma |
[186] |
Complement C3 |
Increased level |
Serum |
[184] |
Immunoglobulin-M (IgM) |
Increased level |
[184] |
Immunoglobulin-A (IgA) |
Decreased level |
[187] |
Nitric oxide |
Higher expression of nitric oxide synthase and increased apoptosis in heart muscles |
Heart ventricle |
Myocardial ischemic-reperfusion injury, cardiac disorders |
[175, 176] |
Hexokinase |
Increased activity |
Brain |
Decreased energy production, body weight loss, lethargy, skeletal muscular atrophy, anorexia |
[188] |
Glucose-6-phosphatase |
Decreased activity |
[188] |
Glucose, glucose-6-phosphate, and pyruvate |
Significant fall in their levels |
Brain (cerebral frontal lobe) |
[189] |
Succinate-CoQ reductase |
Decreased in the activity |
Brain (mitochondria of hippocampus and striatum) |
[190] |
CoQH2-cytochrome c reductase |
[190] |
Cytochrome c oxidase |
Brain (mitochondria of the prefrontal cortex, cerebral cortex, cerebellum, hippocampus, and striatum) |
[190] |
Citrate synthase |
Increased activity |
Brain (prefrontal cortex) |
[190] |
Leptin |
Decreased level |
Plasma |
Anorexia, depression, and Alzheimer’s disease |
[189, 191–193] |
Gut microbiota |
Found in blood |
Plasma |
Inflammation and damage in the blood-brain barrier |
[194, 195] |
Noradrenaline (NA) |
Increased release of NA in different brain areas |
Brain, plasma, urine, and cerebrospinal fluid (CSF) |
Associated with most of the disease mentioned above |
[4, 16, 19, 21, 96, 158, 166] |
Gamma amino butyric acid (GABA) |
Increased level |
Brain |
[16] |
Acetylcholine |
Decreased level |
Brain |
[96] |